Physical-first computational biology and quantum materials engineering

Hermes Bio & Materials replaces synthetic approximations with verified physical calculations across 26 therapeutic targets and 5 advanced material domains, coupling genomic foundation models with three-dimensional structure and orbital solvers.

Four-Stage Physical Verification Stack bio.hermes-ailab.com
Genomic Foundation NVIDIA BioNeMo · Arc Evo 2
40B-parameter nucleotide & regulatory fitness scoring
Stage 1
3D Structure & Folding RunPod Serverless · KTBoltz
All-atom biomolecular complex & pocket confidence
Stage 2
Biophysical Docking AutoDock Vina · RDKit
Binding free energy (kcal/mol) & multiparameter optimization
Stage 3
Quantum Electronic Orbitals DFT · HOMO-LUMO Engine
Bandgap, oxidation stability, and catalytic barrier metrics
Stage 4

26 therapeutic pipelines and 5 advanced material domains

Every candidate undergoes continuous head-to-head benchmarking against global clinical and industrial reference standards. Full structural coordinates and sequences are released exclusively under executed non-disclosure agreements.

Oncology, Immunology & Precision Biologics

14 Therapeutic Programs

De novo design of high-affinity biologics, bispecific antibodies, and allosteric small-molecule inhibitors targeting refractory solid tumors and autoimmune pathways. Candidates are evaluated for target selectivity,epitope stability, and synthetic tractability.

14 Targets Oncology & immune modulation
pLDDT & Kd 3D complex & affinity metrics
18-Pack Due diligence dossier format

Metabolic, CNS & Longevity Therapeutics

12 Therapeutic Programs

Multi-receptor metabolic agonists, blood-brain barrier penetrant neuroprotective scaffolds, and cellular senescence modulators engineered with balanced ADMET and oral bioavailability profiles.

12 Targets Metabolic & neurological scope
MPO Score CNS & oral drug-likeness
Pre-Clinical Synthesis-ready lead packages

Quantum Materials & Energy Storage

5 Industrial Domains

First-principles discovery across carbon-capture hindered amines, solid-state battery electrolytes, deep-blue OLED emitters, extreme-temperature alloys, and green hydrogen electrocatalysts.

5 Domains Energy, display & capture
DFT Verified Electronic & thermal stability
21-Pack Industrial material specification

Global Technology Radar & Reverse Proposals

31 Frontline Benchmarks

Continuous surveillance of global patent filings, clinical trial updates, and preprint repositories to benchmark internal candidates against commercial incumbents in real time.

1:1 Match Incumbent benchmark comparison
Zero-Fraud Raw physical receipts only
B2B Ready Partner-tailored R&D briefs

Two-tier intellectual property boundary for licensing partners

To protect partner exclusivity while enabling rapid scientific evaluation, Hermes Bio & Materials separates every discovery asset into an open validation scorecard and a physically sealed recipe vault.

Disclosure Tier Data Scope Verification & Access Governance
Open Tier (95%) Non-Confidential Validation Scorecard Target class, binding free energy, structural confidence, multiparameter physicochemical scores, and head-to-head benchmark margins against commercial standards.
Sealed Tier (5%) Proprietary Sequence & Molecular Recipe Vault Full amino acid sequences, CDR loops, exact molecular graphs, precursor synthesis routes, and 18/21-item regulatory dossiers remain isolated until CDA/MTA execution.
Audit Trail Cryptographic Physical Compute Receipts Every reported metric is backed by raw GPU and C++ solver execution logs suitable for institutional pharmaceutical and chemical due diligence.

Pharmaceutical & Materials Licensing Desk

Request non-confidential target scorecards, schedule a technical due diligence briefing, or initiate a confidential disclosure agreement (CDA) for full dossier inspection.

Division Portal
https://bio.hermes-ailab.com
Licensing & CDA Desk
Live Discovery Platform Access (Guest / VIP)

Holders of an authorized Guest Passcode issued by Hermes AI Lab can enter the live computational drug and materials discovery platform directly below.